ACM
Advisors Capital Management’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $110M | Buy |
591,096
+11,317
| +2% | +$2.1M | 1.5% | 9 |
|
|
2025
Q1 | $121M | Buy |
579,779
+12,221
| +2% | +$2.56M | 1.88% | 4 |
|
|
2024
Q4 | $101M | Buy |
567,558
+12,381
| +2% | +$2.2M | 1.59% | 8 |
|
|
2024
Q3 | $110M | Buy |
555,177
+9,211
| +2% | +$1.82M | 1.78% | 6 |
|
|
2024
Q2 | $93.6M | Buy |
545,966
+20,174
| +4% | +$3.46M | 1.63% | 6 |
|
|
2024
Q1 | $95.7M | Buy |
525,792
+23,518
| +5% | +$4.28M | 1.75% | 5 |
|
|
2023
Q4 | $77.8M | Buy |
502,274
+5,143
| +1% | +$797K | 1.58% | 6 |
|
|
2023
Q3 | $74.1M | Buy |
497,131
+15,353
| +3% | +$2.29M | 1.88% | 5 |
|
|
2023
Q2 | $64.9M | Sell |
481,778
-6,089
| -1% | -$820K | 1.55% | 6 |
|
|
2023
Q1 | $77.8M | Buy |
487,867
+2,663
| +0.5% | +$424K | 2.01% | 4 |
|
|
2022
Q4 | $78.4M | Sell |
485,204
-17,640
| -4% | -$2.85M | 2.13% | 4 |
|
|
2022
Q3 | $76.3M | Buy |
502,844
+10,979
| +2% | +$1.67M | 2.04% | 4 |
|
|
2022
Q2 | $75.3M | Sell |
491,865
-5,192
| -1% | -$795K | 2.29% | 4 |
|
|
2022
Q1 | $80.6M | Buy |
497,057
+8,333
| +2% | +$1.35M | 2.2% | 4 |
|
|
2021
Q4 | $66.2M | Buy |
488,724
+77,415
| +19% | +$10.5M | 1.8% | 5 |
|
|
2021
Q3 | $44.4M | Buy |
411,309
+18,720
| +5% | +$2.02M | 1.35% | 9 |
|
|
2021
Q2 | $44.2M | Buy |
392,589
+2,965
| +0.8% | +$334K | 1.4% | 10 |
|
|
2021
Q1 | $42.2M | Buy |
389,624
+126,047
| +48% | +$13.6M | 1.48% | 10 |
|
|
2020
Q4 | $28.2M | Buy |
263,577
+9,115
| +4% | +$977K | 1.08% | 22 |
|
|
2020
Q3 | $22.3M | Sell |
254,462
-550
| -0.2% | -$48.2K | 1.04% | 29 |
|
|
2020
Q2 | $25M | Buy |
255,012
+246,781
| +2,998% | +$24.2M | 1.24% | 20 |
|
|
2020
Q1 | $627K | Buy |
8,231
+4,359
| +113% | +$332K | 0.04% | 190 |
|
|
2019
Q4 | $343K | Buy |
+3,872
| New | +$343K | 0.02% | 283 |
|